
How low can you go? Achieved blood pressure and cardiovascular outcomes.
Publication
, Journal Article
Wyatt, CM; Cheung, AK
Published in: Kidney International
September 2017
The benefits of controlling blood pressure to levels < 140/90 mm Hg are well established, but the risks and benefits of further reductions in blood pressure are less clear. A recent observational study using pooled data from 2 large randomized trials of renin-angiotensin system blockers suggested no added benefit and some increased risk of cardiovascular events with achieved blood pressures < 120 mm Hg systolic or 70 mm Hg diastolic. Caveats of observational studies notwithstanding, these results add to the ongoing controversy over the optimal blood pressure target for high-risk individuals.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Kidney International
DOI
EISSN
1523-1755
ISSN
0085-2538
Publication Date
September 2017
Volume
92
Issue
3
Start / End Page
536 / 539
Related Subject Headings
- Urology & Nephrology
- Renin-Angiotensin System
- Hypertension
- Humans
- Blood Pressure Determination
- Blood Pressure
- Antihypertensive Agents
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wyatt, C. M., & Cheung, A. K. (2017). How low can you go? Achieved blood pressure and cardiovascular outcomes. Kidney International, 92(3), 536–539. https://doi.org/10.1016/j.kint.2017.07.002
Wyatt, Christina M., and Alfred K. Cheung. “How low can you go? Achieved blood pressure and cardiovascular outcomes.” Kidney International 92, no. 3 (September 2017): 536–39. https://doi.org/10.1016/j.kint.2017.07.002.
Wyatt CM, Cheung AK. How low can you go? Achieved blood pressure and cardiovascular outcomes. Kidney International. 2017 Sep;92(3):536–9.
Wyatt, Christina M., and Alfred K. Cheung. “How low can you go? Achieved blood pressure and cardiovascular outcomes.” Kidney International, vol. 92, no. 3, Sept. 2017, pp. 536–39. Epmc, doi:10.1016/j.kint.2017.07.002.
Wyatt CM, Cheung AK. How low can you go? Achieved blood pressure and cardiovascular outcomes. Kidney International. 2017 Sep;92(3):536–539.

Published In
Kidney International
DOI
EISSN
1523-1755
ISSN
0085-2538
Publication Date
September 2017
Volume
92
Issue
3
Start / End Page
536 / 539
Related Subject Headings
- Urology & Nephrology
- Renin-Angiotensin System
- Hypertension
- Humans
- Blood Pressure Determination
- Blood Pressure
- Antihypertensive Agents
- 1103 Clinical Sciences